» Articles » PMID: 32993133

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Sep 30
PMID 32993133
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Rearranged during transfection (RET) is the tyrosine kinase receptor that under normal circumstances interacts with ligand at the cell surface and mediates various essential roles in a variety of cellular processes such as proliferation, differentiation, survival, migration, and metabolism. RET plays a pivotal role in the development of both peripheral and central nervous systems. RET is expressed from early stages of embryogenesis and remains expressed throughout all life stages. Mutations either activating or inhibiting RET result in several aggressive diseases, namely cancer and Hirschsprung disease. However, the physiological ligand-dependent activation of RET receptor is important for the survival and maintenance of several neuronal populations, appetite, and weight gain control, thus providing an opportunity for the development of disease-modifying therapeutics against neurodegeneration and obesity. In this review, we describe the structure of RET, its signaling, and its role in both normal conditions as well as in several disorders. We highlight the differences in the signaling and outcomes of constitutive and ligand-induced RET activation. Finally, we review the data on recently developed small molecular weight RET agonists and their potential for the treatment of various diseases.

Citing Articles

New tetrahydroisoquinolines bearing nitrophenyl group targeting HSP90 and RET enzymes: synthesis, characterization and biological evaluation.

Bakhite E, Hassanien R, Farhan N, Sayed E, Sharaky M BMC Chem. 2025; 19(1):46.

PMID: 39985107 PMC: 11846289. DOI: 10.1186/s13065-025-01399-0.


A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration.

Isik F, Thomson S, Cueto J, Spathos J, Breit S, Tsai V Front Immunol. 2024; 15:1514518.

PMID: 39737171 PMC: 11682991. DOI: 10.3389/fimmu.2024.1514518.


Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations.

Xia C, Alliey-Rodriguez N, Tamminga C, Keshavan M, Pearlson G, Keedy S Mol Psychiatry. 2024; .

PMID: 39709506 DOI: 10.1038/s41380-024-02876-z.


Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations.

Xia C, Alliey-Rodriguez N, Tamminga C, Keshavan M, Pearlson G, Keedy S medRxiv. 2024; .

PMID: 39677452 PMC: 11643284. DOI: 10.1101/2024.12.05.24318404.


Lineage-specific intersection of endothelin and GDNF signaling in enteric nervous system development.

Poltavski D, Cunha A, Tan J, Sucov H, Makita T Elife. 2024; 13.

PMID: 39641974 PMC: 11623925. DOI: 10.7554/eLife.96424.


References
1.
Du Z, Lovly C . Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018; 17(1):58. PMC: 5817791. DOI: 10.1186/s12943-018-0782-4. View

2.
Schuchardt A, DAgati V, Costantini F, Pachnis V . Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994; 367(6461):380-3. DOI: 10.1038/367380a0. View

3.
Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S . Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease. Brain. 2019; 142(3):512-525. PMC: 6391602. DOI: 10.1093/brain/awz023. View

4.
Kramer E, Liss B . GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 2015; 589(24 Pt A):3760-72. DOI: 10.1016/j.febslet.2015.11.006. View

5.
Ban K, Feng S, Shao L, Ittmann M . RET Signaling in Prostate Cancer. Clin Cancer Res. 2017; 23(16):4885-4896. PMC: 5609835. DOI: 10.1158/1078-0432.CCR-17-0528. View